Abstract
The increasing prevalence of resistance to conventional antibiotics in pathogenic bacteria has demanded faster development of novel sources of antibacterial agents. In this context, biological activities shown by natural compounds have received particular attention. One of the alleged backslashes for these alternative bactericidal tools is the current knowledge gap regarding their action mechanisms. Here, we evaluated the activity of essential oil extracted of Negramina, Siparuna guianensis, plants against pathogenic bacteria Escherichia coli, Staphylococcus aureus, Pseudomonas aeruginosa and Streptococcus pyogenes. We evaluated cytotoxic effects on bacterial cells and the action mechanisms of the essential oil. The gas chromatography analysis revealed that β-Myrcene (39.68%), epicurzerenone (18.16%) and germacrenes D (14.34%) and B (2.93%) are the major components of the S. guianensis essential oil. Interestingly, the essential oil exhibited toxicity against all pathogenic bacteria without affecting the human monocytic THP-1 cell line. This antibacterial activity resulted from strong bacterial growth inhibition and deregulation of bacterial cell wall permeability with increased nucleotides and K+ ions leakage. Furthermore, our molecular docking predictions indicated high affinity between some essential oil major components Germacrene B and active sites of bacterial DNA and RNA polymerases, which indicates possible impairments on the pathogenic bacteria cell replication processes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.